However, it is found that overexpression of PRRX1 is closely related to tumor EMT, tumor stemness, tumor metastasis, and prognosis in pancreatic cancer (30), colorectal cancer (26), and papillary thyroid cancer (31). This evidence concerns the gene PRRX1 and familial pancreatic carcinoma.